The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
251
The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Positioned to Take Advantage of Growing Support, Legislative Changes

- Timing of expansion into CBD market correlated with passing of 2018 Farm Bill
- MORE Act decriminalizes marijuana, has passed the House
- Reclassification of cannabis by the UN may increase medical research, impact legalization efforts globally

Founded in 2012, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) quickly earned a reputation as one of the fastest-growing and most innovative lifestyle brands. Now a leading producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, WTER’s flagship product was a premium 8.8 pH balanced alkaline drinking water produced through an innovative, state-of-the-art proprietary electrolysis process.

In 2018, WTER became publicly traded thanks to a disciplined growth strategy that soon expanded into the CBD space. The timing was perfect for this new endeavor. The 2018 Farm Bill passed, and CBD had become a buzz word in the health and wellness industry. WTER partnered with Centuria Foods and launched A88CBD(TM) in 2020, a product line (https://nnw.fm/hekSl) that only uses CBD sourced from hemp lawfully grown and processed within the United States.

But the United States hasn’t always been supportive of CBD. In 1937 under the Marihuana Tax Act, all parts of the marijuana plant were made illegal. In 1970 under the Controlled Substances Act, cannabis of any kind was prohibited. That changed in 2018 with the Farm Bill’s passing.

The 2018 Farm Bill played a large part in WTER’s story and expansion by allowing for hemp cultivation and the selling of hemp products under 0.3 percent THC (https://nnw.fm/gERH9). As new bills make their way across the House and Senate floors, WTER is looking forward to what it means for the company and the industry at large. New bills could lead to the long-awaited FDA guidance on CBD-infused consumer products.

An example of this type of legislations is the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) of 2019, which passed the House and is now awaiting approval in the Senate and then the White House. This marks the first time that a federal legislative body has ever voted to decriminalize marijuana. If the MORE Act passes both House and Senate and the President’s desk, marijuana will be removed from the list of scheduled substances. Criminal penalties will also be removed (https://nnw.fm/MRG3U). This is a strong step forward in removing stigmas and creating therapeutic options for consumers.

In addition to decriminalizing marijuana, the bill will put into motion several other changes, including:

- The ability for cannabis-related businesses to acquire loans and services not previously available
- Cannabis will no longer be used as a reason to allow for deportation or the rejection of asylum claims
- Those in prison for marijuana charges will receive a sentencing review for potentially reduced sentencing
- Federal cannabis sales tax of 5% of the sale price to pay for opportunity grants for communities most impacted by the war on drugs

The MORE Act is a step toward legal cannabis diversity and inclusion. While the future of the bill remains in question, the fact that it has progressed as far as it has indicates significant progress for cannabis in both government and popular support.

And the growing acceptance and changes aren’t only being seen in the United States. The United Nations recently voted to reclassify cannabis as a less dangerous drug (https://nnw.fm/RwXUj). This change holds the potential to increase medical research into the therapeutic benefits and impact legalization efforts globally.

“With the apparent change in administration in the U.S., we believe that the FDA guidance on CBD will be forthcoming soon,” said WTER CEO Richard Wright (https://nnw.fm/ssx7R). “Being the National Consumer Products goods company, we feel we are positioned very well to take advantage of any changes that would allow us to sell in all the states.”

For more information, visit the company’s website at www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://nnw.fm/WTER

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Alkaline Water Company Inc. (WTER) Stock Research Links

WTER Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 254

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 238

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

FCPT Expands Portfolio with $3.5 Million Veterinary Acquisition

Updated Category News Views 166

FCPT's Recent Acquisition Highlights Strategic Growth Four Corners Property Trust (NYSE:FCPT) has recently made headlines by acquiring a National Veterinary Associates property for $3.5 million. This acquisition signifies a notable addition to their expanding portfolio, reflecting FCPT's commitment to strategically investing in quality real estate. Details of the...

Continue Reading
Impact of National Security Probe on RH Stock Performance

Updated Category News Views 137

Unveiling the Impact of Recent National Security Investigations Shares of luxury furniture retailer RH have taken a significant hit due to President Donald Trump's announcement of a national security probe into furniture imports. This scrutiny has raised concerns across the home furnishings industry, known for its heavy reliance on global supply chains. Key Takeaways from...

Continue Reading
Understanding the Trends in Constellation Brands' Short Interest

Updated Category News Views 207

Exploring Constellation Brands' Short Interest Constellation Brands, identified by the ticker STZ, has recently reported an increase in its short percent of float, now at 10.22% since the last analysis. The company's latest data shows a total of 7.48 million shares sold short. This figure constitutes 4.42% of all available regular shares for trading. With an analysis...

Continue Reading
CTL's New Modular Monitor Aims to Redefine Flexibility

Updated Category News Views 7

CTL Unveils Innovative Modular Desktop Solutions CTL's latest move in the tech world features a new set of modular desktop products designed to cater to the education, enterprise, and government sectors. Their fresh offering—the CTL MTIP24OPS 24" Open Pluggable Specification (OPS)-Ready Monitor—comes along with two All-in-One computers operating on ChromeOS. This...

Continue Reading
Franklin Universal Trust Declares Monthly Share Distribution

Updated Category News Views 143

Franklin Universal Trust Announces Monthly Distribution Franklin Universal Trust [NYSE: FT] has declared a monthly distribution of $0.0425 per share, aimed at shareholders who are on record. This distribution is derived from net investment income and is set to be paid in the near future. Investment Objectives of the Fund The primary investment goal of Franklin Universal...

Continue Reading